Landmark Bench Study Shows Dramatic Improvement in Ventricular Catheter Placement Accuracy with inTRAvent Medical’s First in Class, FDA-Cleared SOLOPASS 2.0 Ultrasound-Guided Neuronavigation System
inTRAvent Medical Partners LP, a pioneer in bedside, image-guided neurosurgical innovation, today announced the publication of a peer-reviewed study in Neurosurgery evaluating the accuracy of external ventricular drain (EVD) placement using its ultrasound-guided neuronavigation platform, SOLOPASS® 2.0.
Dr. Adam S. Arthur Joins inTRAvent Medical as the Chief Clinical Strategy Officer to Lead Clinical Strategy and Guide Platform Development
inTRAvent Medical, a medical device company dedicated to bringing intra-operative imaging and navigation to the bedside to improve neurosurgical procedures, proudly announces the appointment of Dr. Adam S. Arthur, MD, MPH, as Chief Clinical Strategy Officer (CCSO). In this role, Dr. Arthur will lead the company’s clinical strategy for the upcoming launch of inTRAvent’s platform for external ventricular drain (EVD) placement, SOLOPASS®, while guiding the development of additional minimally invasive applications.
